Two Diagnostic Challenges in Hepatitis B Serology: Low HBsAg S/CO Values and Isolated Anti-HBc Positivity
Pathogens · 22.07.2026 · 15 (7) · 777
DOI: 10.3390/pathogens15070777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 22.07.2026. Verfasst von Şerife Yılmaz Gürbüz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Medical Faculty, Karabuk University, 78050 Karabuk, Turkey. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B Antibodies, Hepatitis B, Hepatitis B virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatitis B surface antigen (HBsAg) signal-to-cutoff (S/CO) values and isolated anti-HBc positivity represent two significant diagnostic challenges in hepatitis B virus (HBV) serology. This retrospective study, conducted in Karabuk between 2021 and 2025, aimed to evaluate the correlation between these profiles and HBV DNA positivity to determine the optimal S/CO thresholds for confirmatory testing and clarify the clinical relevance of isolated anti-HBc reactivity. Among 17,356 patients screened for anti-HBc, isolated anti-HBc positivity was identified in 506 patients (2.9%), of whom 3.2% had detectable HBV DNA. Positivity was significantly higher in patients older than 50 years and in the Gastroenterology department. Separately, 213 specimens with HBsAg S/CO values between 1.0 and 10.0 underwent HBV DNA confirmation testing. ROC analysis yielded an excellent area under the curve of 0.937, with an S/CO threshold of ≥3.04, achieving 100% sensitivity for HBV DNA detection. All specimens with S/CO values between 1.0 and 3.0 were HBV DNA-negative. In this study population, no serum HBV DNA positivity was detected among samples with S/CO values below 3.04, suggesting that HBV DNA testing may help avoid unnecessary confirmatory work-up in this range. Anti-HBc screening should be prioritized in older patients. S/CO-based confirmatory algorithm using HBV DNA testing may improve diagnostic accuracy and reduce unnecessary clinical interventions in routine hepatitis B screening programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Medical Faculty, Karabuk University, 78050 Karabuk, Turkey.
- Medical Microbiology Laboratory, Karabuk Training and Research Hospital, 78100 Karabuk, Turkey.
- Medical Microbiology Laboratory, Çorlu State Hospital, 59850 Tekirdağ, Turkey.
ORCID-Profile: Oğuzhan Yağdı
Zitieren
APA
Yılmaz Gürbüz, Ş., Yağdı, O., & Başar, E. (2026). Two Diagnostic Challenges in Hepatitis B Serology: Low HBsAg S/CO Values and Isolated Anti-HBc Positivity. Pathogens, 15(7), 777. https://doi.org/10.3390/pathogens15070777
Vancouver
Yılmaz Gürbüz Ş, Yağdı O, Başar E. Two Diagnostic Challenges in Hepatitis B Serology: Low HBsAg S/CO Values and Isolated Anti-HBc Positivity. Pathogens. 2026;15(7):777. doi:10.3390/pathogens15070777
BibTeX
@article{YlmazGrbz2026,
author = {Yılmaz Gürbüz, Şerife and Yağdı, Oğuzhan and Başar, Erhan},
title = {Two Diagnostic Challenges in Hepatitis B Serology: Low HBsAg S/CO Values and Isolated Anti-HBc Positivity},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {7},
pages = {777},
doi = {10.3390/pathogens15070777}
}
EUVIMED